Alpelisib tablets-150mg (PIVIKTO)
Alpelisib Tablets 150mg (PIVIKTO) is a targeted anticancer medication designed to treat hormone receptor (HR)-positive, HER2-negative advanced breast cancer. It works by inhibiting the PI3K pathway, which plays a key role in tumor cell growth and survival. This medicine is typically prescribed in combination with hormone therapy to enhance treatment effectiveness. Known for its precision in targeting cancer cells, it helps slow disease progression and improve patient outcomes. Manufactured with high-quality standards, it ensures safety, efficacy, and consistent performance, making it a trusted option in advanced oncology treatment plans.
Description
Alpelisib Tablets 150mg (PIVIKTO) delivers targeted treatment for patients diagnosed with hormone receptor (HR)-positive, HER2-negative advanced breast cancer. This medication actively blocks the PI3K pathway, a critical driver of cancer cell growth and survival. By directly inhibiting this pathway, it helps slow tumor progression and supports better disease management. Doctors often prescribe this therapy in combination with endocrine treatment to enhance its overall effectiveness and improve patient outcomes.
This formulation works with precision, allowing it to target cancer cells while minimizing damage to healthy tissues. Patients benefit from its focused mechanism of action, which helps reduce the risk of rapid disease advancement. The oral tablet form ensures convenient administration and allows patients to follow their treatment regimen with ease under medical supervision.
Manufacturers produce this medicine under strict quality standards to ensure safety, consistency, and reliable performance. Each dose provides accurate strength and maintains stability, which supports effective treatment over time. Healthcare professionals trust this therapy for its proven role in personalized cancer care, especially in patients with specific genetic mutations.
Patients using this medication should follow their prescribed dosage carefully and maintain regular consultations with their healthcare provider. Monitoring helps manage potential side effects and ensures optimal therapeutic results. A balanced treatment approach, including proper nutrition and adherence to medical advice, further supports its effectiveness.
This targeted therapy represents a significant advancement in oncology, offering patients a more focused and efficient option for managing advanced breast cancer. Its role in modern cancer treatment highlights the importance of precision medicine in improving survival and quality of life.
- Brand Name: PIVIKTO
- Generic Name: Alpelisib
- Strength: 150 mg
- Dosage Form: Oral Tablets
- Drug Class: PI3K Inhibitor
- Indication: HR-positive, HER2-negative advanced breast cancer
- Administration: As prescribed by oncologist
- Packaging: Standard pharmaceutical packaging
- Storage: Store in a cool, dry place away from sunlight
